论文部分内容阅读
本文报告口服流感杆菌死菌苗对慢性阻塞性肺痰患(COLD)患者呼吸道感染的特异性防御作用.此项前瞻性双盲安慰剂对照试验是1983年冬季在澳大利亚进行的.将50例确诊的COLD患者随机分为3组:第1组(男10例,女6例,平均65.5±2.9岁)口服葡萄糖肠衣片;第2组(男16例,女1例,平均62岁)口服内含25mg牛磺甘氨胆酸钠的肠衣片;第3组(男14例,女3例,平均64.7±1.64岁)口服内含10~(11)个死
This article reports specific defensive effects of oral influenza bacilli vaccine on respiratory infections in patients with chronic obstructive pulmonary disease (COLD), a prospective, double-blind, placebo-controlled trial conducted in Australia in the winter of 1983. Fifty confirmed Of patients with COLD were randomly divided into three groups: Group 1 (10 males and 6 females, average 65.5 ± 2.9 years) oral gut enteric-coated tablets; Group 2 (16 males and 1 female, average 62 years) orally In the third group (14 males and 3 females, with an average of 64.7 ± 1.64 years), there were 10 to 11 deaths